Last 12 months
Inside the activity.
7 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 2 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 2 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 2 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 1 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2019 Filed Mar 20, 2019 00:35 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
GrantCommon Stock Class A | 4,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000021 · edgardoc.xml · nonDerivative · entry 1 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,727 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2016-2018. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Tax withholdingCommon Stock Class A | 1,628 | $170.14 | $276,987.92 |
DisclosureSEC source: 0001156375-19-000017 · edgardoc.xml · nonDerivative · entry 4 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,377 F2 · shares: Ms. Cronin surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
GrantCommon Stock Class A | 3,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000017 · edgardoc.xml · nonDerivative · entry 3 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,005 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2016-2018. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Tax withholdingCommon Stock Class A | 1,628 | $170.14 | $276,987.92 |
DisclosureSEC source: 0001156375-19-000017 · edgardoc.xml · nonDerivative · entry 2 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,331 F2 · shares: Ms. Cronin surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
GrantCommon Stock Class A | 3,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000017 · edgardoc.xml · nonDerivative · entry 1 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,959 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2016-2018. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC |
Cutinho SunilSr MD & President CME Clearing
|
Tax withholdingCommon Stock Class A | 1,814 | $170.14 | $308,633.96 |
DisclosureSEC source: 0001156375-19-000018 · edgardoc.xml · nonDerivative · entry 4 Cutinho Sunil · CIK 0001619400 · Sr MD & President CME Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,324 F2 · shares: Mr. Cutinho surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC |
Cutinho SunilSr MD & President CME Clearing
|
GrantCommon Stock Class A | 4,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000018 · edgardoc.xml · nonDerivative · entry 3 Cutinho Sunil · CIK 0001619400 · Sr MD & President CME Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,138 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2016-2018. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC |
Cutinho SunilSr MD & President CME Clearing
|
Tax withholdingCommon Stock Class A | 1,977 | $170.14 | $336,366.78 |
DisclosureSEC source: 0001156375-19-000018 · edgardoc.xml · nonDerivative · entry 2 Cutinho Sunil · CIK 0001619400 · Sr MD & President CME Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,676 F2 · shares: Mr. Cutinho surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2019 Filed Mar 20, 2019 00:34 UTC |
Cutinho SunilSr MD & President CME Clearing
|
GrantCommon Stock Class A | 4,462 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000018 · edgardoc.xml · nonDerivative · entry 1 Cutinho Sunil · CIK 0001619400 · Sr MD & President CME Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,653 F1 · shares: Represents shares earned from a 2015 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2016-2018. Read SEC document |
| March 15, 2019 Filed May 13, 2019 16:57 UTC Amendment |
Cutinho SunilSr MD & President CME Clearing
|
Tax withholdingCommon Stock Class A | 1,689 | $170.14 | $287,366.46 |
DisclosureSEC source: 0001156375-19-000042 · edgardoc.xml · nonDerivative · entry 1 Cutinho Sunil · CIK 0001619400 · Sr MD & President CME Clearing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,449 F1 · shares: The original Form 4 filed on March 19, 2019 incorrectly reported 1,814 shares surrendered to the company in order to fulfill tax withholding obligations in connection with receipt of a performance share award. This amendment is being filed to correctly report the amount as 1,689. Read SEC document |
| March 15, 2019 Filed May 13, 2019 16:57 UTC Amendment |
Sammann DerekSr MD Gl Hd Commodity & Option
|
Tax withholdingCommon Stock Class A | 1,405 | $170.14 | $239,046.70 |
DisclosureSEC source: 0001156375-19-000043 · edgardoc.xml · nonDerivative · entry 1 Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Commodity & Option 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,403 F1 · shares: The original Form 4 filed on March 19, 2019 incorrectly reported 1,461 shares surrendered to the company in order to fulfill tax withholding obligations in connection with receipt of a performance share award. This amendment is being filed to correctly report the amount as 1,405. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 18:47 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,021 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001156375-19-000015 · edgardoc.xml · derivative · entry 6 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 7,021 shares Expires 2020-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: As of 9/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 18:47 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,319 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001156375-19-000015 · edgardoc.xml · derivative · entry 5 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,021 Underlying: Common Stock Class A · 1,319 shares Expires 2020-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: As of 9/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 18:47 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
SaleCommon Stock Class A | 7,021 | $167.45 | $1,175,699.45 |
DisclosureSEC source: 0001156375-19-000015 · edgardoc.xml · nonDerivative · entry 4 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,285 F1 · price: On March 14, 2019, Ms. Cronin sold a total of 7,021 shares of CME Group Class A common stock at an average price of $167.45 per share, including the exercise of options. The price ranges were $167.45 through $167.49. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 18:47 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Exercise / conversionCommon Stock Class A | 7,021 | $54.30 | $381,240.30 |
DisclosureSEC source: 0001156375-19-000015 · edgardoc.xml · nonDerivative · entry 3 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 18:47 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
SaleCommon Stock Class A | 1,319 | $168.00 | $221,592.00 |
DisclosureSEC source: 0001156375-19-000015 · edgardoc.xml · nonDerivative · entry 2 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,285 Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 18:47 UTC |
CRONIN KATHLEEN MSr MD Gen Counsel & Corp Secr
|
Exercise / conversionCommon Stock Class A | 1,319 | $54.30 | $71,621.70 |
DisclosureSEC source: 0001156375-19-000015 · edgardoc.xml · nonDerivative · entry 1 CRONIN KATHLEEN M · CIK 0001259107 · Sr MD Gen Counsel & Corp Secr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:54 UTC |
GEPSMAN MARTIN JDirector
|
SaleCommon Stock Class A | 3,000 | $167.91 | $503,730.00 |
DisclosureSEC source: 0001156375-19-000016 · primary_doc.xml · nonDerivative · entry 1 GEPSMAN MARTIN J · CIK 0001212813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,799 Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 19:56 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
SaleCommon Stock Class A | 4,362 | $182.45 | $795,846.90 |
DisclosureSEC source: 0001156375-19-000014 · edgardoc.xml · nonDerivative · entry 1 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,265 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 16:15 UTC |
Pankau Ronald A.Director
|
SaleCommon Stock Class A | 200 | $182.90 | $36,580.00 |
DisclosureSEC source: 0001156375-19-000013 · edgardoc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,600 Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 14:42 UTC |
Bernacchi Jeffrey M.Director
|
SaleCommon Stock Class A | 10,087 | $177.94 | $1,794,880.78 |
DisclosureSEC source: 0001156375-19-000007 · edgardoc.xml · nonDerivative · entry 1 Bernacchi Jeffrey M. · CIK 0001464713 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,004 F1 · price: On February 26, 2019, Mr. Bernacchi sold an aggregate of 10,087 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $177.90 to $177.99 and $178.01 to $178.13. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,740 | $0.00 Strike: $62.83 | $0.00 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · derivative · entry 9 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 1,740 shares Expires 2020-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: As of 3/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,160 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · derivative · entry 8 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 4,160 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: As of 9/15/2013, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12,060 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · derivative · entry 7 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 12,060 shares Expires 2020-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: As of 9/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
SaleCommon Stock Class A | 4,160 | $186.98 | $777,834.72 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 6 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,720 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F3 · price: On January 2, 2019, Mr. Pietrowicz sold an aggregate of 4,160 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $186.25 to $186.97 and $187.00 to $187.65. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
Exercise / conversionCommon Stock Class A | 4,160 | $56.87 | $236,579.20 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 5 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
SaleCommon Stock Class A | 1,740 | $186.90 | $325,201.13 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 4 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,720 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On January 2, 2019, Mr. Pietrowicz sold an aggregate of 13,800 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $186.04 to $186.99 and $187.00 to $187.69. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
Exercise / conversionCommon Stock Class A | 1,740 | $62.83 | $109,324.20 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 3 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,460 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
SaleCommon Stock Class A | 12,060 | $186.90 | $2,253,980.23 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 2 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,720 F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1. F2 · price: On January 2, 2019, Mr. Pietrowicz sold an aggregate of 13,800 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $186.04 to $186.99 and $187.00 to $187.69. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 22:46 UTC |
Pietrowicz John W.Sr MD Chief Financial Officer
|
Exercise / conversionCommon Stock Class A | 12,060 | $54.30 | $654,858.00 |
DisclosureSEC source: 0001156375-19-000001 · edgardoc.xml · nonDerivative · entry 1 Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 16:13 UTC |
Tully SeanSr MD Global Hd Financial & OT
|
SaleCommon Stock Class A | 6,000 | $191.45 | $1,148,700.00 |
DisclosureSEC source: 0001156375-18-000138 · edgardoc.xml · nonDerivative · entry 4 Tully Sean · CIK 0001619542 · Sr MD Global Hd Financial & OT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,328 F1 · price: On December 12, 2018, Mr. Tully sold an aggregate of 6,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $191.10 to $191.65. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 16:13 UTC |
Tully SeanSr MD Global Hd Financial & OT
|
SaleCommon Stock Class A | 5,000 | $191.75 | $958,750.00 |
DisclosureSEC source: 0001156375-18-000138 · edgardoc.xml · nonDerivative · entry 3 Tully Sean · CIK 0001619542 · Sr MD Global Hd Financial & OT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,328 Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 16:13 UTC |
Tully SeanSr MD Global Hd Financial & OT
|
SaleCommon Stock Class A | 2,000 | $192.16 | $384,320.00 |
DisclosureSEC source: 0001156375-18-000138 · edgardoc.xml · nonDerivative · entry 2 Tully Sean · CIK 0001619542 · Sr MD Global Hd Financial & OT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,328 Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 16:13 UTC |
Tully SeanSr MD Global Hd Financial & OT
|
SaleCommon Stock Class A | 500 | $192.00 | $96,000.00 |
DisclosureSEC source: 0001156375-18-000138 · edgardoc.xml · nonDerivative · entry 1 Tully Sean · CIK 0001619542 · Sr MD Global Hd Financial & OT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,328 Read SEC document |
| December 10, 2018 Filed Dec 12, 2018 21:42 UTC |
Pankau Ronald A.Director
|
SaleCommon Stock Class A | 187 | $190.00 | $35,530.00 |
DisclosureSEC source: 0001156375-18-000137 · primary_doc.xml · nonDerivative · entry 1 Pankau Ronald A. · CIK 0001523463 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 Read SEC document |
| November 30, 2018 Filed Dec 6, 2018 17:34 UTC |
Tobin Jack JMD Chief Accounting Officer
|
GiftCommon Stock Class A | 539 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000136 · edgardoc.xml · nonDerivative · entry 2 Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,023 F2 · kind: This transaction involved a gift of securities from the reporting person to his donor advised fund. Read SEC document |
| November 29, 2018 Filed Dec 6, 2018 17:34 UTC |
Tobin Jack JMD Chief Accounting Officer
|
GiftCommon Stock Class A | 165 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000136 · edgardoc.xml · nonDerivative · entry 1 Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,562 F1 · kind: This transaction represented a gift of securities from the reporting person to his adult children, who do not share the reporting person's household. Read SEC document |
| November 23, 2018 Filed Nov 27, 2018 20:46 UTC |
DUFFY TERRENCE ADirector · Chairman and CEO
|
SaleCommon Stock Class A | 10,000 | $188.80 | $1,888,000.00 |
DisclosureSEC source: 0001156375-18-000135 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,652 F1 · price: On November 23, 2018, Mr. Duffy sold an aggregate of 10,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $188.76 to $188.98. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| November 21, 2018 Filed Nov 23, 2018 14:58 UTC |
Carey Charles PDirector
|
SaleCommon Stock Class A | 2,000 | $192.15 | $384,300.00 |
DisclosureSEC source: 0001156375-18-000134 · primary_doc.xml · nonDerivative · entry 2 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Firm Disclosed balance after: 24,141 F2 · price: On November 21, 2018, Mr. Carey sold an aggregate of 2,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices with a $1 range have been aggregated and the weighted average has been reported. The price range was $191.85 to $192.44. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| November 20, 2018 Filed Nov 23, 2018 14:58 UTC |
Carey Charles PDirector
|
SaleCommon Stock Class A | 3,000 | $191.64 | $574,920.00 |
DisclosureSEC source: 0001156375-18-000134 · primary_doc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Firm Disclosed balance after: 26,141 F1 · price: On November 20, 2018, Mr. Carey sold an aggregate of 3,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices with a $1 range have been aggregated and the weighted average has been reported. The price range was $191.04 to $191.90. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 18:19 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,310 | $0.00 Strike: $56.87 | $0.00 |
DisclosureSEC source: 0001156375-18-000133 · edgardoc.xml · derivative · entry 7 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock Class A · 1,310 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: As of 9/15/2013, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 18:19 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,670 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001156375-18-000133 · edgardoc.xml · derivative · entry 6 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,670 Underlying: Common Stock Class A · 2,670 shares Expires 2020-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: As of 9/15/2014, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 18:19 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
SaleCommon Stock Class A | 1,867 | $195.01 | $364,083.67 |
DisclosureSEC source: 0001156375-18-000133 · edgardoc.xml · nonDerivative · entry 5 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,718 F1 · price: On November 16, 2018, Ms. Winkler sold an aggregate of 5,847 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $194.95 to $195.18. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 18:19 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
SaleCommon Stock Class A | 1,310 | $195.01 | $255,463.10 |
DisclosureSEC source: 0001156375-18-000133 · edgardoc.xml · nonDerivative · entry 4 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,585 F1 · price: On November 16, 2018, Ms. Winkler sold an aggregate of 5,847 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $194.95 to $195.18. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 18:19 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Exercise / conversionCommon Stock Class A | 1,310 | $56.87 | $74,499.70 |
DisclosureSEC source: 0001156375-18-000133 · edgardoc.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 18:19 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
SaleCommon Stock Class A | 2,670 | $195.01 | $520,676.70 |
DisclosureSEC source: 0001156375-18-000133 · edgardoc.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,585 F1 · price: On November 16, 2018, Ms. Winkler sold an aggregate of 5,847 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $194.95 to $195.18. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| November 16, 2018 Filed Nov 20, 2018 18:19 UTC |
Winkler JulieSr MD Chief Commercial Officer
|
Exercise / conversionCommon Stock Class A | 2,670 | $54.30 | $144,981.00 |
DisclosureSEC source: 0001156375-18-000133 · edgardoc.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2018 Filed Nov 8, 2018 16:01 UTC |
Holzrichter JulieSr MD Chief Operating Officer
|
SaleCommon Stock Class A | 3,353 | $186.71 | $626,038.63 |
DisclosureSEC source: 0001156375-18-000132 · edgardoc.xml · nonDerivative · entry 1 Holzrichter Julie · CIK 0001409442 · Sr MD Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,627 Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 23:36 UTC |
Spencer Michael ADirector
|
GrantCommon Stock Class A | 3,020,690 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001156375-18-000131 · primary_doc.xml · nonDerivative · entry 1 Spencer Michael A · CIK 0001757667 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,020,690 F1 · price: Received in exchange for shares of NEX Group plc ("NEX") in connection with the acquisition (the "Acquisition") of NEX by CME Group Inc. Pursuant to the terms of Acquisition, NEX shareholders received for each NEX Group ordinary share 500 pence in cash and 0.0444 shares of CME Group Class A common stock. The effective date of the Acquisition was November 2, 2018. The closing price on the trading day prior to the effective date of the Acquisition was $183.75 for CME Group Class A common stock. Immediately prior to the effective date of the Acquisition and the exchange of shares, Mr. Spencer held 68,033,572 shares of NEX. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 22:47 UTC |
Carey Charles PDirector
|
SaleCommon Stock Class A | 2,800 | $183.45 | $513,660.00 |
DisclosureSEC source: 0001156375-18-000129 · primary_doc.xml · nonDerivative · entry 1 Carey Charles P · CIK 0001341358 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,532 F1 · price: On November 2, 2018, Mr. Carey sold an aggregate of 2,800 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price range was $183.30 to $183.64 The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.